Skip to content
Home/Companies/MedTech/Atlantic Therapeutics

Atlantic Therapeutics

MedTech·Ireland·Exited 2023·Held 5yr
Entry
2018
Hold
5yr
Exit
2023

Who owns Atlantic Therapeutics?

Atlantic Therapeutics was owned by Andera Partners through BioDiscovery 5 (2017 vintage) from 2018 to 2023, exited via Trade Sale. Across its history, Atlantic Therapeutics has been through 2 private equity ownership periods, detailed in the timeline below.

Buyer identity available on Pro.

Hand-verified · updated 2026-04-21

Andera Partners
Most recent investor
Andera Partners
BioDiscovery 5 · 2017 · VC
2 ownership periods · full history below

Key facts

HQIreland
SectorMedTech
Key takeaways
  • ·Fully exited in 2023.
  • ·Average hold across 2 realized cycles: 5 years.

Ownership history

2 ownership periods · co-invest detected

Exited
Last exited in 2023 to .
Co-invest · 2 holders · 2018 · 2023
Atlantic Bridge Capital
2018 · 2023(5yr) · Atlantic Bridge III · 2016 · Growth
Trade Sale · to
MOIC
Andera Partners
Andera PartnersExited 2023
2018 · 2023(5yr) · BioDiscovery 5 · 2017 · VC
Trade Sale · to
MOIC
Track Atlantic Therapeutics

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Atlantic Therapeutics?

7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Atlantic Therapeutics.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue